- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Anthera Pharmaceuticals Inc+ Add to Watchlist
ANTH:US0.5999 USD 0.0070 1.15%
As of 20:10:00 ET on 05/24/2013.
Company Profile for Anthera Pharmaceuticals Inc (ANTH)
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
Anthera Pharmaceuticals Inc
Key Executives for Anthera Pharmaceuticals Inc (ANTH)
|Christopher S HenneyChairman||Paul F TruexPresident/CEO/Founder|
|Christopher P LoweCFO/Chief Business Officer||Debra OdinkSenior VP/CTO|
|Colin HislopSenior VP/Chief Medical Ofcr||Paula AdamsVP:Regulatory Affairs|